To study the value of the fatty acid analog tellurium-123m-labeled-9-telluraheptadecanoic acid (123mTe-THDA) as a cardiac imaging agent, five dogs had partial occlusion of the left anterior descending coronary artery. One hour later, scandium-46 ("Sc) microspheres were injected into the left atrium, followed immediately by the i.v. 121mTe-THDA. After injection, regional myocardial 2'SmTe activity was monitored continuously with implanted miniature cadmium telluride radiation detectors in both ischemic and nonischemic zones. After 4 hours, stannum-113 microspheres were injected into the left atrium and the dogs were killed. Ischemic and nonischemic areas of myocardium were sectioned and counted in a well counter.
Tellurium-123m-labeled-9-Telluraheptadecanoic Acid:
A Possible Cardiac Imaging Agent SUMMARY To study the value of the fatty acid analog tellurium-123m-labeled-9-telluraheptadecanoic acid (123mTe-THDA) as a cardiac imaging agent, five dogs had partial occlusion of the left anterior descending coronary artery. One hour later, scandium-46 ("Sc) microspheres were injected into the left atrium, followed immediately by the i.v. 121mTe-THDA. After injection, regional myocardial 2'SmTe activity was monitored continuously with implanted miniature cadmium telluride radiation detectors in both ischemic and nonischemic zones. After 4 hours, stannum-113 microspheres were injected into the left atrium and the dogs were killed. Ischemic and nonischemic areas of myocardium were sectioned and counted in a well counter.
Nonischemic myocardial 123mTe activity reached 88 ± 10% (mean ± SD) of peak activity within 1 minute after injection, peaked in 8 ± 9 minutes, then decreased 2 ± 8% over the next 4 hours. Ischemic myocardial 123mTe activity reached 97 ± 4% of peak activity within 1 minute after injection, peaked in 5 ± 5 minutes, then decreased 5 ± 7% over the next 4 hours. There was a linear correlation between 121mTe activity at 1 hour and at 4 hours and the initial "OSc microsphere-determined regional myocardial blood flow (r = 0.93-0.96). Ischemic and nonischemic zone myocardial blood flows did not change significantly during the experiment. Cardiac images of excellent quality were obtained after 123mTe-THDA administration in three additional dogs with left anterior descending occlusions and two additional dogs with no occlusions using a conventional gamma scintillation camera and a low-energy collimator.
The linear relationship with regional myocardial blood flow, the minimal myocardial washout after a rapid peak, and the 159-keV gamma make lSSmTe-THDA a promising new cardiac perfusion imaging agent. UNDER AEROBIC CONDITIONS, nonesterified long-chain fatty acids are the' major substrate for myocardial energy production.1' 2 As a result of the high utilization by the heart, rapid turnover from the blood, and minimal concentration in normal lung, fatty acids labeled with gamma-emitting radioisotopes might be excellent myocardial imaging agents. However, most of these radiopharmaceuticals are rapidly metabolized with translocation of the tracer label to other sites. The changing distribution of the radiolabel during the imaging interval may decrease image quality and the redistribution may have little relationship to fatty acid metabolism. We prepared a longchain fatty acid, substituting a metallic heteroatom within the alkyl chain.3 5 We postulated that such an organometallic-substituted fatty acid would enter the myocardial cells but would be only partially metabolized, leaving the tracer within the cell. One such family of compounds, tellurium-123m-labeled long-chain fatty acids, has been shown to have high myocardial uptake in preliminary studies in rats. [6] [7] [8] The purposes of the present study were to determine if the initial distribution of tellurium-123m-labeled-9telluraheptadecanoic acid (123mTe-THDA) was proportional to regional myocardial blood flow; to determine if the inter-alkyl location of the 123mTe would protect it from translocation during metabolism of the fatty acid; and, if so, to determine if such an agent could be used to obtain high-quality myocardial images.
Methods

Preparation of Radiopharmaceutical
The '23mTe-THDA was synthesized by coupling sodium octyl (t23mTe) tellurol with methyl-8-bromooctanoate. 6 The methyl ester was stored under argon in a freezer. For each set of experiments, the 123mTe-THDA was freshly prepared by basic hydrolysis of an aliquot of the stock ester as described earlier. 8 The '23mTe-THDA in these studies had a specific activity of 15-30 mCi/mmol. The 123mTe-THDA was dissolved in either an ethanol-propylene glycol solution (1:4) or complexed with a 4-6% solution of dilapidated bovine serum albumin (Sigma Chemical Company). The final solutions were passed through a 0.22-A Millipore filter before i.v. administration.
Myocardial Kinetics of 123mTe-THDA
Five adult mongrel dogs (mean weight 19 kg; range 15-22 kg) were anesthetized with chloralose (140 mg/kg, i.v.) and urethane (1400 mg/kg, i.v.), intubated, and placed on an Emerson respirator with 5 cm of positive end-expiratory pressure and 100% oxygen. The heart was exposed by left thoracotomy and suspended in a pericardial cradle. A 20-cm vinyl catheter was inserted into the left atrium for monitoring left atrial pressure and for injecting microspheres. A second vinyl catheter was inserted into the right atrium for injecting the l2smTe-THDA. A catheter was placed in the brachial artery and positioned in the aortic arch to obtain specimens of blood for determination of arterial pH, Pco2 and Po2, to obtain reference samples for microsphere determination of regional myocardial blood flow and to monitor aortic pressure. The left anterior descending coronary artery was dissected free just above the origin of the regional diagonal branch and a balloon cuff was positioned but not inflated ( fig. 1 II and pressures were monitored continuously with Statham P23Db transducers throughout the experiment and recorded on paper with a Hewlett-Packard recorder (model 7788A). Specimens of arterial blood were obtained at frequent intervals to assess pH, Po2 and Pco2, and appropriate adjustments were made to maintain these variables in the physiologic range (pH 7.35-7.45, Pco2 30-40 mm Hg). Arterial Po2 was maintained above 100 mm Hg throughout the experiment.
Miniature cadmium telluride radiation detectors were inserted through the left ventricular apex and positioned against the endocardium distal to the left anterior descending coronary artery occluder and in the region of the left circumflex coronary artery. The properties of these detectors have been described.9 Detector-measured myocardial activity has been shown to correlate well with activity from serial myocardial punch biopsies (r = 0.90). The detectors were connected through preamplifiers to a multichannel analyzer (Canberra Series 30) which allowed continuous monitoring and display of l23mTe activity.
The experimental protocol is shown in figure 1 . The left anterior descending coronary artery was occluded such that distal artery pressure was 30-35 mm Hg. One hour later, approximately 4.5 million 4"Sc-labeled 8-10-,u microspheres were administered into the left atrium (30 ,sCi total activity) (New England Nuclear Corporation). The microspheres were suspended in 2 ml of normal saline and 0.01% Tween-80 by agitation in a vortex mixer for 5 minutes. After background counts from the radiation detectors were obtained, '23mTe-THDA (250 ,Ci) was injected intravenously. The l23mTe activity was monitored continuously for 4 hours in the ischemic and nonischemic zones of the heart. One-milliliter arterial blood samples for 123mTe activity were collected at 2, 4, 6, 8, 10, 20, 30, 60, 90, 120, 180 and 240 minutes after injection. Before sacrifice at 4 hours, a second set of microspheres labeled with stannum-113 (113Sn) was administered into the left atrium. The total number, mean size and total radioactivity of the "3sSn microspheres were the same as for the 4"Sc microspheres.
At the termination of the experiment, methylene blue was injected into the proximal left anterior descending coronary artery, the dog was sacrificed, the heart was removed, and the left ventricular free wall was dissected into an ischemic and a nonischemic zone. The ischemic zone was determined by dissecting along the branches of the left anterior descending coronary artery, which was constricted by the occluder. The ischemic and nonischemic samples were subdivided into 24-60 pieces each, including both endocardial and epicardial pieces. Each sample weighed 1-3 g fresh. The samples were counted in a well counter for 5 minutes to collect at least 10,000 counts for each isotope. The l23mTe was counted at 96-176 keV, "'Sn at 350-435 keV, and 4"Sc at 820-1300 keV. A computer program was used to correct for activity crossing over from one window into another. The constants for the corrections were obtained by counting standards of each tracer in each of the counting windows. Regional myocardial blood EXPERIMENTAL PROTOCOL Ba/loon Occluder Distol Pressure flow was calculated by the computer from the sample activity and activity in reference blood samples obtained simultaneously with the administration of the "i3sn and 4"Sc.10
Cardiac Imaging Studies
In three other dogs, the miniature radiation detectors were omitted. After occlusion of the left anterior descending coronary artery and injection of the "Sc microspheres, the chest wall was closed. The 123Te-THDA (50 ACi) was injected intravenously and myocardial images were obtained in the anterior, left anterior oblique and left lateral projections. Images were collected for 10 minutes in each projection, using an upgraded Searle HP3 gamma camera with a 1.25cm-thick Nal crystal (Nuclear Services, Inc.), and the 159-keV photopeak with a 20% window. A lowenergy, all-purpose, parallel-hole collimator was used. Data were recorded in a 64 X 64 matrix in a dedicated nuclear medicine computer system (Hewlett-Packard model 5407A). One hour after the '2smTe-THDA administration, the dogs were sacrificed and the heart was processed.
In two additional anesthetized dogs without coronary artery occlusions, 50 gCi of l23mTe-THDA were administered intravenously. Myocardial imaging was performed initially and after 5 days.
Statistical Methods
Results are mean ± SD. The significance of a difference between means was assessed using the t test. The significance of correlations between l23mTe activity and initial 4"fSc microsphere-determined myocardial blood flow was assessed using linear regression analysis. Blood time-activity curves were analyzed using a computer-assisted nonlinear leastsquares estimation of the decay constants (X min-').
Results
Hemodynamic and Flow Measurements
Heart rate, mean arterial pressure and mean left atrial pressure were not significantly different at the time l2amTe-THDA was administered and 4 hours later: heart rate, 160 ± 26 and 159 ± 17 beats/min, respectively; mean arterial pressure, 128 ± 10 and 130 ± 17 mm Hg; and mean left atrial pressure, 4.2 ± 1.0 and 4.6 ± 0.5 mm Hg. Before '23mTe-THDA administration, mean myocardial blood flow was 0.56 ± 0.19 ml/min/g (range 0.31-0.73 ml/min/g) in the ischemic zone and 0.95 ± 0.17 ml/min/g (range 0.98-1.10 ml/min/g) in the nonischemic zone (ischemic/nonischemic flow ratio 0.58 ± 0.16). Four hours after l23mTe-THDA administration, mean myocardial blood flow was 0.60 + 0.16 ml/min/g (NS compared with initial value) in the ischemic zone and 1.13 0.49 ml/min/g (NS compared with initial value) in the nonischemic zone (ischemic/nonischemic flow ratio 0.57 ± 0.13; NS compared with initial value). Four hours after '23nTe-THDA administration, the mean ratio of ischemic zone/nonischemic zone.23nTe activity was 0.60 + 0.21 (NS compared with initial and delayed flow ratios). Nonischemic myocardial zone 123mTe activity reached 88 ± 10% of peak activity within 1 minute, peaked in 8 ± 9 minutes, then decreased 2 + 8% over the next 4 hours. Ischemic myocardial zone 123mTe activity reached 97 ± 4% of peak activity within 1 minute, peaked in 5 + 5 minutes, then decreased 5 + 7% over the next 4 hours (all NS compared with the nonischemic zone). Figure 2 is a typical 12amTe timeactivity curve for nonischemic myocardium. Figure 3 is a typical l23mTe time-activity curve for ischemic myocardium.
There was a linear correlation between l23mTe activity at the time of sacrifice and initial "Sc microsphere-determined regional myocardial blood flow for the dogs sacrificed I hour and 4 hours after l23mTe-THDA administration. The number of myocardial samples and the correlation coefficient for each of the three dogs sacrificed after 1 hour were n = 123, r = 0.94; n = 57, r = 0.98; n = 62, r = 0.93. Figure 4 shows this relationship in one dog sacrificed 1 hour after l2amTe-THDA administration. The correlation appeared to be better at lower regional blood flows. The number of myocardial samples and the correlation coefficient for each of the five dogs sacrificed after 4 hours were n -48, r = 0.95; n = 48, r = 0.93; n = 48, r 0.93; n 48, r = 0.96; n = 48, r = 0.95. Figure   5 shows this relationship for one dog sacrificed 4 hours after '23mTe-THDA administration. The offset of this line compared with that for the dog sacrificed at 1 hour is due to the small amount of 123mTe-THDA myocardial clearance between 1 and 4 hours. The ischemic zone 123mTe endocardial/epicardial activity ratio was 0.82 + 0. ratio of 0.81 ± 0.09. The normal zone l23mTe endocardial/epicardial activity ratio was 1.00 + 0.04 compared with an initial microsphere-determined blood flow endocardial/epicardial ratio of 1.01 + 0.12.
The l2SmTe blood activity decreased triexponentially. The mean first, second and third decay constants were: A, = 0.4815 + 0.1380 minm', A2 = 0.1861 ± 0.0188 min-' and As = 0.0020 + 0.0003 min-'. Twenty minutes after administration, l23mTe blood activity was 14.6 ± 4.8% of the 2-minute activity.
Cardiac Imaging Studies
Typical 12smTe cardiac images obtained from dogs with no coronary artery stenosis are shown in figures 6 (initial images) and 7 (5-day images). The lowest heart-to-lung count density ratio for the initial images was 3.0/1.0. The myocardial clearance of 123mTe-THDA at 5 days was 39%. Figure 8 shows typical "23mTe cardiac images obtained from dogs with a left anterior descending coronary artery occlusion.
Discussion
Radiolabeled fatty acids have been studied as potentially excellent myocardial imaging agents because of their high utilization by the heart, rapid blood clearance, and minimal lung uptake." 2 Sobel and associates have used carbon-1 I-labeled palmitic acid and positron-emission transaxial tomography to image normal, ischemic, and infarcted myocardium in man and in laboratory animals.'"' Because the myocardial clearance rate of fatty acids depends on myocardial metabolism, the group has also used the clearance rate of carbon-1 1-palmitic acid to noninvasively assess myocardial metabolism."' 16 Unfortunately, the technique requires the expense of an onsite cyclotron (physical half-life of "IC is 20 minutes) and a positron camera. Furthermore, the short halflife and rapid myocardial clearance of "IC-labeled palmitate make static imaging difficult. Radioiodinated long-chain fatty acids have also been proposed as cardiac imaging agents.'7 23 However, the rapid myocardial clearance and the high blood levels of these radiopharmaceuticals limit their value for static imaging. The rapid myocardial clearance of the radiolabeled long-chain fatty acids appears to be due to metabolism of the fatty acid with translocation of the radiotracer to other sites. Accordingly, Knapp and associates have synthesized a family of long-chain fatty acids substituting a metallic heteroatom within the alkyl chain.' It was postulated that the inter-alkyl location of the LAOL t heteroatom would protect it from translocation. One such radiopharmaceutical, l23mTe-THDA, has shown high myocardial uptake.6 In organ distribution studies in rats, we demonstrated the highest 123mTe-THDA uptake in the heart.7 Pinhole-collimator cardiac images in these rats demonstrated decreased activity in regions of myocardial infarction. Other studies from our laboratory have demonstrated threefold higher '23mTe activities in normal compared with infarcted rat myocardium. The normal rat myocardium accumulated 3.7% of the 123mTe-THDA total body dose per gram of tissue. The present study demonstrates that 12smTe-THDA accumulates rapidly in normal and ischemic canine myocardium. The uptake is proportional to regional myocardial blood flow. There is then minimal clearance of 123mTe from normal and ischemic myocardium over the next 4 hours.
In the present study the myocardial kinetics of 123mTe was monitored using implantable miniature radiation detectors. These detectors allowed precise regional monitoring of activity, previously only possible using serial myocardial punch or drill biopsies. However, compared with multiple biopsies, the implantable radiation detectors avoid trauma to the myocardium and allow continuous monitoring of activity and assessment of myocardial lsmTe activity from precisely the same area of myocardium.
The physical half-life of 12smTe is 120 days, but the biologic half-life is only 7 days. Elmaleh and associates7 showed that the radiation dose estimates for 250 ACi of 123mTe-THDA are acceptable and comparable to estimates for 2 mCi of thallium-201 (201TI).
In the present study, i.v. administration of 123mTe-THDA produced no changes over 4 hours in heart rate, arterial pressure, left atrial pressure, and nonischemic and ischemic myocardial blood flows, suggesting no hemodynamic toxicity at the dose used. However, Elmaleh and associates7 also demonstrated some toxic effects in rats given very high doses of '23mTe-THDA. Thus, further toxicity studies are necessary before considering 123mTe-THDA for myocardial imaging in man.
Although there is good myocardial uptake of l23mTe-THDA in rat and canine myocardium, further studies are needed to demonstrate satisfactory uptake of the tracer in man, because a species variation in the handling of this complex agent may exist. Furthermore, although the slow myocardial clearance of '23mTe-THDA would be advantageous for initial imaging and for the demonstration of the presence or absence of disease, serial studies could not be performed at short intervals. Thus, the evaluation of interventions might be difficult.
Compared with 201TI, imaging with '23Te-THDA has several potential advantages. The 159-keV gamma emissions would be more favorable for gamma camera imaging. Initial imaging with '23mTe-THDA would be facilitated by the lack of changing tracer distribution as occurs with thallium-201. Both early and late myocardial '23mTe-THDA distribution are related to regional myocardial blood flow. A potential disadvantage of '23mTe-THDA compared with 201TI is the inability to distinguish viable from nonviable myocardium using an analysis of redistribution after tracer administration. Also, 123mTe-THDA may not be as linearly related to regional myocardial blood flow at higher compared with lower flows.
In conclusion, 123mTe-THDA is rapidly taken up by nonischemic and ischemic canine myocardium in proportion to regional myocardial blood flow. After achieving peak myocardial concentration, there is very slow washout of l23mTe from both the nonischemic and ischemic myocardium. This slow 123mTe myocardial washout, the rapid clearance from the blood, and the 159-keV gamma emissions allow excellent static myocardial images in dogs. Thus, l23mTe-THDA merits further investigation as a cardiac imaging agent in man.
